Quality of life in patients with inflammatory bowel diseases in the Czech Republic – a multicentre study
Original articleGastroent Hepatol 2018; 72(1): 11–19. doi:10.14735/amgh201811
SummaryLiteraturepdf Dana Ďuricová, Martina Pfeiferová, Martin Bortlík, Barbora Pipek, Ivana Mikoviny Kajzrlíková, Karel Dušek, Milan Lukáš, Pacientská organizace Pacienti IBDPregnancy outcomes in women with inflammatory bowel disease treated with biosimilar infliximab
Original articleGastroent Hepatol 2018; 72(1): 20–26. doi:10.14735/amgh201820
SummaryLiteraturepdf Martin Kolář, Martin Bortlík, Dana Ďuricová, Martin Lukáš, Veronika Hrubá, Naděžda Machková, Karin Malíčková, Milan LukášEfficacy of ustekinumab in a patient refractory to other biological treatment
Case reportGastroent Hepatol 2018; 72(1): 47–49. doi:10.14735/amgh201847
SummaryLiteraturepdf Martin Bortlík, Naděžda Machková, Veronika Hrubá, Martin Lukáš, Dana Ďuricová, Karin Malíčková, Zuzana Šerclová, Milan LukášGastroenterology and renal diseases
Review articleGastroent Hepatol 2018; 72(1): 50–57. doi:10.14735/amgh201850
SummaryLiteraturepdf Vladimír Teplan, Olga Marečková, Milan LukášAnswer to the quiz
Answer to the quizGastroent Hepatol 2018; 72(1): 85–86.
Literaturepdf Milan Lukáš"Distal" ulcerative colitis in the elderly – what is the therapeutic procedure to choose?
QuizGastroent Hepatol 2018; 72(2): 96–97.
pdf Milan LukášEsomeprazole – S-isomer of omeprazole with more favorable pharmacological properties and stronger pharmacodynamic effect
Drug profileGastroent Hepatol 2018; 72(2): 179–181. doi:10.14735/amgh2018179
Literaturepdf Milan LukášWhat was the cause of a huge stomach ulcer?
QuizGastroent Hepatol 2018; 72(3): 192.
pdf Milan Lukáš